Free Trial

The Hanover Insurance Group (THG) Financials

The Hanover Insurance Group logo
$168.05 +1.13 (+0.68%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$168.12 +0.06 (+0.04%)
As of 06/20/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for The Hanover Insurance Group

Annual Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
332 155 186 391 425 359 423 116 35 426
Consolidated Net Income / (Loss)
332 155 186 391 425 359 423 116 35 426
Net Income / (Loss) Continuing Operations
331 67 216 239 429 362 420 117 34 425
Total Pre-Tax Income
439 66 293 283 522 445 521 144 41 538
Total Revenue
4,988 4,173 4,228 4,464 4,747 4,801 5,075 5,500 5,973 6,195
Net Interest Income / (Expense)
-61 -51 -45 -45 -38 -37 -34 -34 -34 -34
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
61 51 45 45 38 37 34 34 34 34
Long-Term Debt Interest Expense
61 51 45 45 38 37 34 34 34 34
Total Non-Interest Income
5,048 4,225 4,274 4,510 4,784 4,838 5,109 5,534 6,007 6,229
Other Service Charges
31 23 23 23 26 27 24 27 31 28
Net Realized & Unrealized Capital Gains on Investments
313 413 271 237 286 283 315 255 313 288
Premiums Earned
4,705 3,790 3,980 4,254 4,475 4,527 4,770 5,252 5,663 5,913
Total Non-Interest Expense
4,548 4,107 3,935 4,139 4,331 4,353 4,672 5,292 5,926 5,675
Property & Liability Insurance Claims
2,884 2,546 2,580 2,725 2,866 2,845 3,134 3,623 4,135 3,757
Other Operating Expenses
631 730 510 522 539 557 555 574 608 690
Amortization Expense
1,033 804 841 892 927 951 983 1,093 1,176 1,222
Impairment Charge
- 27 5.60 - - - - 1.90 7.70 5.80
Nonoperating Income / (Expense), net
- - - -43 107 - 119 -63 -5.60 14
Income Tax Expense
109 -1.00 77 44 93 83 101 27 7.60 113
Net Income / (Loss) Discontinued Operations
0.70 -1.00 -30 152 -3.90 -3.30 2.80 -0.80 1.80 0.70
Basic Earnings per Share
$7.55 $3.63 $4.38 $9.21 $10.62 $9.52 $11.78 $3.26 $0.99 $11.85
Weighted Average Basic Shares Outstanding
43.90M 42.80M 42.50M 42.40M 40M 37.70M 35.90M 35.60M 35.70M 35.90M
Diluted Earnings per Share
$7.40 $3.59 $4.33 $9.09 $10.46 $9.42 $11.60 $3.21 $0.98 $11.70
Weighted Average Diluted Shares Outstanding
44.80M 43.20M 43M 43M 40.60M 38.10M 36.40M 36.10M 36.10M 36.40M
Weighted Average Basic & Diluted Shares Outstanding
43.90M 42.70M 42.50M 40.57M 38.45M 36.39M 35.48M 35.60M 35.82M 35.93M

Quarterly Income Statements for The Hanover Insurance Group

This table shows The Hanover Insurance Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Consolidated Net Income / (Loss)
0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Net Income / (Loss) Continuing Operations
0.60 -12 -12 -70 8.20 107 116 40 102 167 128
Total Pre-Tax Income
0.50 -15 -18 -91 -0.90 150 145 51 130 212 160
Total Revenue
1,366 1,518 1,442 1,499 1,513 1,519 1,536 1,531 1,546 1,583 1,594
Net Interest Income / (Expense)
-8.50 -8.60 -8.50 -8.60 -8.50 -8.50 -8.50 -8.60 -8.50 -8.50 -8.50
Total Interest Income
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense
8.50 8.60 8.50 8.60 8.50 8.50 8.50 8.60 8.50 8.50 8.50
Long-Term Debt Interest Expense
8.50 8.60 8.50 8.60 8.50 8.50 8.50 8.60 8.50 8.50 8.50
Total Non-Interest Income
1,395 1,456 1,451 1,507 1,522 1,527 1,545 1,539 1,554 1,591 1,602
Other Service Charges
7.00 7.10 8.00 7.80 7.40 7.60 7.30 7.60 6.70 6.40 6.40
Net Realized & Unrealized Capital Gains on Investments
73 70 78 88 83 64 88 58 68 73 87
Premiums Earned
1,331 1,364 1,380 1,412 1,431 1,440 1,449 1,473 1,479 1,512 1,509
Other Non-Interest Income
-16 - -15 - - - 0.30 - - - 0.00
Total Non-Interest Expense
1,357 1,486 1,453 1,588 1,509 1,376 1,397 1,480 1,428 1,370 1,435
Property & Liability Insurance Claims
940 1,051 1,017 1,140 1,062 916 935 1,008 954 861 955
Other Operating Expenses
141 150 147 154 151 156 163 166 165 196 165
Amortization Expense
277 284 289 293 297 298 299 304 308 311 314
Nonoperating Income / (Expense), net
-29 - -7.10 -1.10 -5.20 7.80 6.50 1.10 12 -5.10 1.00
Income Tax Expense
-0.10 -2.80 -5.50 -21 -9.10 43 30 11 28 44 32
Basic Earnings per Share
$0.01 ($0.34) ($0.34) ($1.94) $0.24 $3.03 $3.22 $1.13 $2.84 $4.66 $3.56
Weighted Average Basic Shares Outstanding
35.60M 35.60M 35.60M 35.70M 35.80M 35.70M 35.80M 36M 36M 35.90M 36M
Diluted Earnings per Share
$0.01 ($0.33) ($0.34) ($1.94) $0.24 $3.02 $3.18 $1.12 $2.80 $4.60 $3.50
Weighted Average Diluted Shares Outstanding
36.10M 36.10M 35.60M 35.70M 36.10M 36.10M 36.30M 36.30M 36.50M 36.40M 36.60M
Weighted Average Basic & Diluted Shares Outstanding
35.56M 35.60M 35.73M 35.75M 35.76M 35.82M 35.94M 35.98M 36.03M 35.93M 35.92M

Annual Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-35 -56 94 648 -808 -95 110 74 11 120
Net Cash From Operating Activities
445 743 705 551 603 708 824 722 362 806
Net Cash From Continuing Operating Activities
445 743 705 188 603 708 824 722 362 806
Net Income / (Loss) Continuing Operations
332 155 186 0.00 425 359 423 116 35 426
Consolidated Net Income / (Loss)
332 155 186 - 425 359 423 116 35 426
Depreciation Expense
30 31 30 -25 22 18 17 13 6.30 1.50
Amortization Expense
13 9.90 14 9.70 11 6.00 3.40 5.50 7.90 6.80
Non-Cash Adjustments to Reconcile Net Income
-21 92 -11 -224 -91 21 -100 135 63 107
Changes in Operating Assets and Liabilities, net
91 456 486 790 235 304 481 453 249 265
Net Cash From Investing Activities
-172 -495 -506 271 -312 -609 -460 -508 -229 -541
Net Cash From Continuing Investing Activities
-172 -495 -506 271 -312 -609 -460 -508 -229 -541
Purchase of Property, Leasehold Improvements and Equipment
-20 -16 -19 -13 -13 -15 -8.00 -18 -12 -10
Purchase of Investment Securities
-2,222 -2,372 -1,878 -1,604 -1,921 -2,084 -2,303 -2,085 -1,131 -3,313
Divestitures
44 - - 636 35 0.00 0.00 0.00 0.00 0.00
Sale and/or Maturity of Investments
2,026 1,892 1,390 1,253 1,587 1,490 1,851 1,595 914 2,782
Net Cash From Financing Activities
-301 -301 -112 -171 -1,099 -194 -253 -141 -122 -146
Net Cash From Continuing Financing Activities
-301 -301 -112 -171 -1,099 -194 -253 -141 -122 -146
Repurchase of Common Equity
-127 -106 -37 -58 -564 -213 -163 -31 0.00 -27
Payment of Dividends
-74 -80 -87 -94 -386 -100 -102 -109 -117 -124
Other Financing Activities, Net
15 -10 12 -7.40 1.60 -2.20 12 -0.90 -4.90 5.30
Other Net Changes in Cash
- - - - 3.30 0.00 0.00 0.00 0.00 -0.60
Cash Interest Paid
61 53 48 48 37 34 33 33 33 33
Cash Income Taxes Paid
57 30 51 57 114 97 74 108 -22 149

Quarterly Cash Flow Statements for The Hanover Insurance Group

This table details how cash moves in and out of The Hanover Insurance Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
19 140 -124 -14 127 22 -52 77 86 8.60 -121
Net Cash From Operating Activities
315 199 18 26 225 93 59 140 395 214 39
Net Cash From Continuing Operating Activities
315 199 18 26 225 93 59 140 395 214 39
Net Income / (Loss) Continuing Operations
0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Consolidated Net Income / (Loss)
0.50 -12 -12 -69 8.60 108 116 41 102 168 128
Depreciation Expense
3.80 2.90 2.20 1.80 1.50 0.80 0.80 0.80 0.50 -0.60 -1.10
Amortization Expense
1.40 1.40 2.00 2.00 1.90 2.00 1.70 1.70 1.70 1.70 1.60
Non-Cash Adjustments to Reconcile Net Income
53 -25 30 11 15 7.90 1.20 43 21 42 25
Changes in Operating Assets and Liabilities, net
257 232 -4.00 81 198 -26 -61 54 269 2.50 -115
Net Cash From Investing Activities
-259 -31 -107 -12 -68 -42 -75 -34 -282 -150 -112
Net Cash From Continuing Investing Activities
-259 -31 -107 -12 -68 -42 -75 -34 -282 -150 -112
Purchase of Property, Leasehold Improvements and Equipment
-4.00 -3.90 -3.50 -3.30 -2.90 -2.20 -2.60 -2.20 -2.40 -3.00 -1.80
Purchase of Investment Securities
-474 -563 -283 -206 -313 -329 -304 -935 -957 -1,118 -828
Sale and/or Maturity of Investments
219 536 180 198 248 289 232 903 677 970 717
Net Cash From Financing Activities
-38 -27 -35 -29 -29 -29 -35 -29 -27 -55 -48
Net Cash From Continuing Financing Activities
-38 -27 -35 -29 -29 -29 -35 -29 -27 -55 -48
Repurchase of Common Equity
-10 - 0.00 - - - 0.00 - - -27 -11
Payment of Dividends
-27 -29 -29 -29 -29 -30 -31 -31 -31 -32 -32
Other Financing Activities, Net
-0.50 1.90 -6.20 0.40 -0.40 1.30 -4.90 2.00 3.90 4.30 -4.10
Other Net Changes in Cash
- - - - - - - - - -0.20 0.50

Annual Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
13,781 14,220 15,470 12,400 12,491 13,444 14,254 13,995 14,613 15,275
Cash and Due from Banks
339 283 298 1,021 216 121 231 305 316 436
Trading Account Securities
7,560 7,916 6,326 6,626 7,263 8,053 8,385 7,724 8,116 8,700
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income
63 62 48 53 53 51 50 55 58 70
Unearned Premiums Asset
1,392 1,438 1,096 1,177 1,260 1,339 1,470 1,601 1,706 1,801
Deferred Acquisition Cost
509 518 430 451 467 478 552 605 621 663
Goodwill
186 185 179 179 179 179 179 179 179 179
Other Assets
3,733 3,820 7,094 2,894 3,052 3,223 3,388 3,527 3,617 3,427
Total Liabilities & Shareholders' Equity
13,781 14,220 15,470 12,400 12,491 13,444 14,254 13,995 14,613 15,275
Total Liabilities
10,937 11,363 12,472 9,445 9,574 10,242 11,109 11,661 12,147 12,433
Short-Term Debt
- - - - - - - - 0.00 62
Other Short-Term Payables
725 728 - 910 628 688 908 732 776 758
Long-Term Debt
803 786 787 778 653 781 782 782 783 722
Claims and Claim Expense
6,574 6,949 5,059 5,304 5,654 6,024 6,448 7,013 7,308 7,461
Unearned Premiums Liability
2,541 2,561 2,132 2,278 2,417 2,483 2,735 2,954 3,103 3,283
Other Long-Term Liabilities
294 338 4,495 175 222 267 238 181 177 146
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842
Total Preferred & Common Equity
2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,844 2,858 2,998 2,955 2,916 3,202 3,145 2,334 2,466 2,842
Common Stock
1,834 1,847 1,858 1,872 1,838 1,858 1,888 1,914 1,940 1,974
Retained Earnings
1,804 1,876 1,975 2,182 2,411 2,668 2,983 2,993 2,909 3,210
Treasury Stock
-847 -928 -943 -984 -1,485 -1,696 -1,848 -1,871 -1,866 -1,886
Accumulated Other Comprehensive Income / (Loss)
54 63 108 -117 153 373 122 -702 -517 -456

Quarterly Balance Sheets for The Hanover Insurance Group

This table presents The Hanover Insurance Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets
13,746 14,092 14,187 14,315 14,594 14,872 15,367 15,470
Cash and Due from Banks
165 182 168 295 265 338 427 315
Trading Account Securities
7,600 7,913 7,831 7,742 8,153 8,198 8,770 8,969
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income
50 54 56 56 58 62 64 66
Unearned Premiums Asset
1,624 1,600 1,674 1,771 1,740 1,814 1,882 1,809
Deferred Acquisition Cost
600 598 606 631 619 635 663 657
Goodwill
179 179 179 179 179 179 179 179
Other Assets
3,528 3,566 3,674 3,641 3,581 3,648 3,382 3,475
Total Liabilities & Shareholders' Equity
13,746 14,092 14,187 14,315 14,594 14,872 15,367 15,470
Total Liabilities
11,450 11,703 11,949 12,199 12,071 12,320 12,489 12,426
Short-Term Debt
- - - - - - - 62
Other Short-Term Payables
723 619 652 728 679 735 775 619
Long-Term Debt
782 783 783 783 783 784 784 723
Claims and Claim Expense
6,774 7,143 7,313 7,330 7,331 7,463 7,427 7,609
Unearned Premiums Liability
2,972 2,969 3,021 3,188 3,105 3,168 3,339 3,259
Other Long-Term Liabilities
199 189 180 170 173 170 164 155
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044
Total Preferred & Common Equity
2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,296 2,389 2,238 2,116 2,523 2,552 2,878 3,044
Common Stock
1,905 1,914 1,924 1,932 1,942 1,953 1,964 1,979
Retained Earnings
3,030 2,952 2,853 2,832 2,994 3,003 3,075 3,307
Treasury Stock
-1,873 -1,869 -1,868 -1,868 -1,864 -1,863 -1,861 -1,897
Accumulated Other Comprehensive Income / (Loss)
-766 -608 -671 -780 -549 -541 -300 -345

Annual Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-0.28% -16.33% 1.32% 5.58% 6.32% 1.14% 5.71% 8.37% 8.60% 3.72%
EBITDA Growth
11.23% -77.90% 216.14% -7.72% 44.24% 5.24% -10.44% -46.62% -73.02% 767.49%
EBIT Growth
16.24% -84.98% 343.79% 11.27% 27.52% 7.77% -10.14% -48.50% -77.47% 1,013.49%
NOPAT Growth
17.18% -79.75% 222.54% 27.59% 23.86% 6.01% -10.49% -48.11% -77.36% 987.81%
Net Income Growth
17.55% -53.21% 20.05% 109.99% 8.72% -15.62% 17.87% -72.56% -69.57% 1,106.80%
EPS Growth
17.83% -51.49% 20.61% 109.93% 15.07% -9.94% 23.14% -72.33% -69.47% 1,093.88%
Operating Cash Flow Growth
-21.25% 67.17% -5.22% -21.76% 9.36% 17.37% 16.41% -12.31% -49.92% 122.95%
Free Cash Flow Firm Growth
1,197.59% -83.61% 6.80% 334.64% 53.94% -110.19% 840.36% 157.14% -109.67% 139.07%
Invested Capital Growth
-2.67% -0.10% 3.86% -1.37% -4.37% 11.58% -1.42% -20.64% 4.26% 11.61%
Revenue Q/Q Growth
-1.85% -11.89% 0.92% 11.52% 2.30% 0.91% 0.59% 4.33% 0.04% 1.17%
EBITDA Q/Q Growth
-6.95% -70.93% 148.53% -12.10% 29.39% 15.01% -8.80% -29.45% 227.41% 14.95%
EBIT Q/Q Growth
-5.08% -79.66% 212.93% 3.49% 13.99% 16.52% -9.10% -31.02% 173.54% 15.66%
NOPAT Q/Q Growth
-3.59% -72.78% 164.18% 2.16% 13.77% 14.13% -23.41% -42.32% 143.92% 20.19%
Net Income Q/Q Growth
-3.58% -37.00% 53.63% 22.61% -3.14% 18.03% 0.71% -60.77% 141.68% 16.39%
EPS Q/Q Growth
-3.14% -36.68% 53.55% 22.84% -1.32% 20.15% 2.75% -60.71% 141.35% 15.61%
Operating Cash Flow Q/Q Growth
-12.97% 14.32% -1.54% -13.70% 18.49% -2.48% 8.90% -3.96% -22.63% 17.62%
Free Cash Flow Firm Q/Q Growth
31.30% -23.92% -54.74% 21.96% 65.11% -137.69% -19.85% -10.81% -202.71% 108.85%
Invested Capital Q/Q Growth
-1.16% -5.20% 0.69% -0.73% -4.93% 1.21% 1.10% 1.23% 12.05% -0.98%
Profitability Metrics
- - - - - - - - - -
EBITDA Margin
9.67% 2.55% 7.97% 6.97% 9.45% 9.83% 8.33% 4.10% 1.02% 8.53%
EBIT Margin
8.81% 1.58% 6.93% 7.30% 8.76% 9.33% 7.93% 3.77% 0.78% 8.39%
Profit (Net Income) Margin
6.65% 3.72% 4.40% 8.76% 8.96% 7.47% 8.33% 2.11% 0.59% 6.88%
Tax Burden Percent
75.44% 235.00% 63.57% 138.41% 81.42% 80.64% 81.10% 80.56% 85.89% 79.21%
Interest Burden Percent
100.00% 100.00% 100.00% 86.68% 125.63% 99.31% 129.52% 69.46% 88.01% 103.42%
Effective Tax Rate
24.72% -1.52% 26.22% 15.40% 17.83% 18.62% 19.43% 18.89% 18.49% 20.92%
Return on Invested Capital (ROIC)
8.95% 1.84% 5.82% 7.34% 9.35% 9.59% 8.19% 4.78% 1.20% 12.05%
ROIC Less NNEP Spread (ROIC-NNEP)
9.03% 12.92% 2.02% 22.07% 21.04% 9.13% 20.84% -1.89% 0.84% 13.57%
Return on Net Nonoperating Assets (RNNOA)
2.71% 3.60% 0.54% 5.80% 5.13% 2.14% 5.13% -0.54% 0.28% 4.01%
Return on Equity (ROE)
11.66% 5.44% 6.36% 13.14% 14.48% 11.73% 13.32% 4.23% 1.47% 16.05%
Cash Return on Invested Capital (CROIC)
11.65% 1.94% 2.03% 8.72% 13.82% -1.36% 9.62% 27.79% -2.97% 1.08%
Operating Return on Assets (OROA)
3.19% 0.47% 1.97% 2.34% 3.34% 3.45% 2.91% 1.47% 0.33% 3.48%
Return on Assets (ROA)
2.41% 1.11% 1.25% 2.81% 3.42% 2.77% 3.05% 0.82% 0.25% 2.85%
Return on Common Equity (ROCE)
11.66% 5.44% 6.36% 13.14% 14.48% 11.73% 13.32% 4.23% 1.47% 16.05%
Return on Equity Simple (ROE_SIMPLE)
11.65% 5.43% 6.21% 13.23% 14.58% 11.20% 13.44% 4.97% 1.43% 14.99%
Net Operating Profit after Tax (NOPAT)
331 67 216 276 341 362 324 168 38 414
NOPAT Margin
6.63% 1.61% 5.11% 6.18% 7.19% 7.54% 6.39% 3.06% 0.64% 6.68%
Net Nonoperating Expense Percent (NNEP)
-0.08% -11.09% 3.80% -14.73% -11.68% 0.46% -12.64% 6.67% 0.35% -1.52%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
91.19% 98.42% 93.07% 92.70% 91.24% 90.67% 92.07% 96.23% 99.22% 91.61%
Earnings before Interest and Taxes (EBIT)
439 66 293 326 416 448 403 207 47 520
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
482 107 337 311 449 472 423 226 61 528
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.96 1.08 1.24 1.39 1.66 1.25 1.39 1.95 1.72 1.96
Price to Tangible Book Value (P/TBV)
1.03 1.15 1.32 1.47 1.76 1.32 1.48 2.12 1.85 2.09
Price to Revenue (P/Rev)
0.55 0.74 0.88 0.92 1.02 0.83 0.86 0.83 0.71 0.90
Price to Earnings (P/E)
8.24 19.83 20.02 10.47 11.35 11.16 10.35 39.29 119.96 13.08
Dividend Yield
2.67% 2.60% 2.32% 2.30% 5.88% 2.47% 2.32% 2.39% 2.77% 2.23%
Earnings Yield
12.13% 5.04% 4.99% 9.55% 8.81% 8.96% 9.66% 2.55% 0.83% 7.64%
Enterprise Value to Invested Capital (EV/IC)
0.88 0.98 1.11 1.03 1.47 1.17 1.26 1.62 1.45 1.63
Enterprise Value to Revenue (EV/Rev)
0.64 0.86 1.00 0.86 1.11 0.97 0.97 0.92 0.79 0.96
Enterprise Value to EBITDA (EV/EBITDA)
6.63 33.58 12.51 12.38 11.73 9.88 11.66 22.31 77.20 11.21
Enterprise Value to EBIT (EV/EBIT)
7.28 54.24 14.40 11.81 12.67 10.41 12.24 24.29 100.68 11.39
Enterprise Value to NOPAT (EV/NOPAT)
9.66 53.43 19.52 13.96 15.42 12.88 15.21 29.95 123.52 14.30
Enterprise Value to Operating Cash Flow (EV/OCF)
7.19 4.82 5.99 6.98 8.73 6.59 5.98 6.97 13.00 7.34
Enterprise Value to Free Cash Flow (EV/FCFF)
7.42 50.70 55.93 11.75 10.43 0.00 12.95 5.15 0.00 160.17
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.28 0.28 0.26 0.26 0.22 0.24 0.25 0.34 0.32 0.28
Long-Term Debt to Equity
0.28 0.28 0.26 0.26 0.22 0.24 0.25 0.34 0.32 0.25
Financial Leverage
0.30 0.28 0.27 0.26 0.24 0.23 0.25 0.29 0.33 0.30
Leverage Ratio
4.84 4.91 5.07 4.68 4.24 4.24 4.36 5.16 5.96 5.63
Compound Leverage Factor
4.84 4.91 5.07 4.06 5.33 4.21 5.65 3.58 5.25 5.82
Debt to Total Capital
22.02% 21.58% 20.79% 20.84% 18.30% 19.60% 19.91% 25.11% 24.11% 21.63%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.70%
Long-Term Debt to Total Capital
22.02% 21.58% 20.79% 20.84% 18.30% 19.60% 19.91% 25.11% 24.11% 19.92%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
77.98% 78.42% 79.21% 79.16% 81.70% 80.40% 80.09% 74.89% 75.89% 78.38%
Debt to EBITDA
1.67 7.38 2.34 2.50 1.46 1.65 1.85 3.47 12.86 1.48
Net Debt to EBITDA
0.96 4.73 1.45 -0.78 0.98 1.40 1.30 2.12 7.67 0.66
Long-Term Debt to EBITDA
1.67 7.38 2.34 2.50 1.46 1.65 1.85 3.47 12.86 1.37
Debt to NOPAT
2.43 11.74 3.64 2.82 1.91 2.16 2.41 4.65 20.58 1.89
Net Debt to NOPAT
1.40 7.52 2.26 -0.88 1.28 1.82 1.70 2.84 12.27 0.84
Long-Term Debt to NOPAT
2.43 11.74 3.64 2.82 1.91 2.16 2.41 4.65 20.58 1.74
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
431 71 75 328 504 -51 381 979 -95 37
Operating Cash Flow to CapEx
2,280.51% 4,735.03% 3,788.17% 4,208.40% 4,533.08% 4,748.99% 10,296.25% 4,057.87% 3,039.50% 7,905.88%
Free Cash Flow to Firm to Interest Expense
7.11 1.37 1.67 7.27 13.45 -1.39 11.19 28.70 -2.78 1.08
Operating Cash Flow to Interest Expense
7.34 14.46 15.59 12.22 16.08 19.07 24.23 21.18 10.61 23.65
Operating Cash Flow Less CapEx to Interest Expense
7.02 14.16 15.18 11.93 15.72 18.67 23.99 20.66 10.26 23.35
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.36 0.30 0.28 0.32 0.38 0.37 0.37 0.39 0.42 0.41
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
3,648 3,644 3,785 3,733 3,570 3,983 3,927 3,116 3,249 3,626
Invested Capital Turnover
1.35 1.14 1.14 1.19 1.30 1.27 1.28 1.56 1.88 1.80
Increase / (Decrease) in Invested Capital
-100 -3.60 141 -52 -163 413 -57 -810 133 377
Enterprise Value (EV)
3,197 3,580 4,217 3,850 5,264 4,663 4,928 5,035 4,702 5,922
Market Capitalization
2,732 3,076 3,728 4,093 4,827 4,002 4,377 4,558 4,235 5,573
Book Value per Share
$65.77 $67.17 $70.58 $69.80 $74.03 $85.96 $88.39 $65.62 $68.94 $78.87
Tangible Book Value per Share
$61.47 $62.82 $66.37 $65.57 $69.49 $81.16 $83.36 $60.60 $63.94 $73.90
Total Capital
3,648 3,644 3,785 3,733 3,570 3,983 3,927 3,116 3,249 3,626
Total Debt
803 786 787 778 653 781 782 782 783 784
Total Long-Term Debt
803 786 787 778 653 781 782 782 783 722
Net Debt
464 504 489 -243 438 660 551 477 467 349
Capital Expenditures (CapEx)
20 16 19 13 13 15 8.00 18 12 10
Net Nonoperating Expense (NNE)
-0.70 -88 30 -115 -84 3.30 -99 52 2.76 -12
Net Nonoperating Obligations (NNO)
803 786 787 778 653 781 782 782 783 784
Total Depreciation and Amortization (D&A)
43 41 44 -15 33 24 20 18 14 8.30
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$7.55 $3.63 $4.38 $9.21 $10.62 $9.52 $11.67 $3.26 $0.99 $11.85
Adjusted Weighted Average Basic Shares Outstanding
43.90M 42.80M 42.50M 42.40M 40M 37.70M 35.90M 35.60M 35.70M 35.90M
Adjusted Diluted Earnings per Share
$7.40 $3.59 $4.33 $9.09 $10.46 $9.42 $11.49 $3.21 $0.98 $11.70
Adjusted Weighted Average Diluted Shares Outstanding
44.80M 43.20M 43M 43M 40.60M 38.10M 36.40M 36.10M 36.10M 36.40M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $10.62 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
42.82M 42.50M 42.50M 40.57M 38.45M 36.39M 35.48M 35.60M 35.82M 35.93M
Normalized Net Operating Profit after Tax (NOPAT)
331 65 220 276 341 362 324 170 44 419
Normalized NOPAT Margin
6.63% 1.57% 5.21% 6.18% 7.19% 7.54% 6.39% 3.09% 0.74% 6.76%
Pre Tax Income Margin
8.81% 1.58% 6.93% 6.33% 11.00% 9.27% 10.27% 2.62% 0.69% 8.68%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
7.25 1.28 6.48 7.23 11.08 12.07 11.84 6.08 1.37 15.25
NOPAT to Interest Expense
5.46 1.30 4.78 6.11 9.11 9.76 9.53 4.93 1.12 12.14
EBIT Less CapEx to Interest Expense
6.93 0.98 6.07 6.94 10.73 11.67 11.60 5.56 1.02 14.95
NOPAT Less CapEx to Interest Expense
5.14 1.00 4.37 5.82 8.75 9.36 9.30 4.41 0.77 11.84
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
22.38% 51.84% 46.62% 24.12% 90.85% 27.74% 24.17% 93.88% 332.01% 29.13%
Augmented Payout Ratio
60.78% 119.92% 66.60% 38.87% 223.43% 87.06% 62.63% 120.43% 332.01% 35.40%

Quarterly Metrics And Ratios for The Hanover Insurance Group

This table displays calculated financial ratios and metrics derived from The Hanover Insurance Group's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.91% 17.67% 9.08% 15.91% 10.76% 0.01% 6.50% 2.13% 2.14% 4.22% 3.75%
EBITDA Growth
-69.98% -72.07% -104.62% -309.78% -45.77% 297.81% 2,383.87% 161.42% 1,459.74% 47.31% 12.95%
EBIT Growth
-78.67% -74.32% -108.04% -344.14% -52.22% 342.24% 1,437.50% 156.03% 2,641.86% 49.44% 14.63%
NOPAT Growth
2.79% -106.32% -106.91% -188.96% -91.53% 1,088.61% 1,615.56% 163.03% 2,986.04% 68.42% 15.47%
Net Income Growth
-98.53% -107.22% -111.44% -404.85% 1,620.00% 991.74% 1,062.50% 158.53% 1,087.21% 55.61% 11.00%
EPS Growth
-98.94% -107.13% -111.72% -407.94% 2,300.00% 1,015.15% 1,035.29% 157.73% 1,066.67% 52.32% 10.06%
Operating Cash Flow Growth
10.02% -13.05% -90.95% 204.65% -28.69% -53.30% 224.31% 432.44% 75.66% 130.31% -33.73%
Free Cash Flow Firm Growth
875.16% 264.85% 36.80% -58.52% -78.38% -103.87% -105.55% -201.96% -468.19% -564.36% -1,535.30%
Invested Capital Growth
-20.74% -20.64% -12.26% -9.93% -5.81% 4.26% 4.24% 10.43% 26.29% 11.61% 15.81%
Revenue Q/Q Growth
5.68% 11.12% -4.89% 3.90% 0.98% 0.34% 1.67% -0.36% 0.99% 2.39% 0.70%
EBITDA Q/Q Growth
-65.28% 157.04% -116.99% -1,283.87% 108.97% 1,785.71% -2.48% -62.78% 127.89% 78.10% -25.39%
EBIT Q/Q Growth
-75.48% 257.78% -132.30% -761.54% 104.80% 3,211.63% -2.32% -63.91% 134.86% 80.49% -25.24%
NOPAT Q/Q Growth
-49.62% -128.97% 29.25% -761.54% 104.80% 3,279.66% 8.46% -64.17% 134.96% 84.45% -25.64%
Net Income Q/Q Growth
-97.80% -2,520.00% 0.83% -476.67% 112.43% 1,154.65% 7.04% -64.94% 152.10% 64.45% -23.65%
EPS Q/Q Growth
-98.41% -3,400.00% -3.03% -470.59% 112.37% 1,158.33% 5.30% -64.78% 150.00% 64.29% -23.91%
Operating Cash Flow Q/Q Growth
3,563.95% -37.00% -90.88% 44.75% 757.63% -58.75% -36.68% 137.65% 182.94% -45.91% -81.78%
Free Cash Flow Firm Q/Q Growth
29.03% -4.88% -45.54% -37.95% -32.76% -117.04% 21.97% -1,040.68% -142.83% 69.26% -92.06%
Invested Capital Q/Q Growth
-8.22% 1.23% 1.78% -4.76% -4.02% 12.05% 1.76% 0.90% 9.76% -0.98% 5.59%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
1.04% 2.40% -0.43% -5.73% 0.51% 9.56% 9.22% 3.44% 7.77% 13.52% 10.01%
EBIT Margin
0.66% 2.12% -0.72% -5.98% 0.28% 9.38% 9.06% 3.28% 7.63% 13.45% 9.98%
Profit (Net Income) Margin
0.04% -0.80% -0.83% -4.62% 0.57% 7.11% 7.52% 2.65% 6.61% 10.61% 8.04%
Tax Burden Percent
100.00% 82.31% 68.57% 76.30% -955.56% 71.84% 79.49% 78.95% 78.72% 79.39% 80.08%
Interest Burden Percent
5.56% -45.65% 168.27% 101.23% -20.93% 105.48% 104.46% 102.19% 110.01% 99.39% 100.63%
Effective Tax Rate
-20.00% 0.00% 0.00% 0.00% 0.00% 28.56% 20.51% 21.25% 21.28% 20.90% 19.93%
Return on Invested Capital (ROIC)
3.94% -1.06% -0.84% -7.65% 0.40% 12.57% 13.44% 4.95% 11.22% 19.51% 14.01%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.54% -1.29% -1.44% -8.48% 1.11% 13.36% 14.10% 5.07% 12.39% 19.07% 14.11%
Return on Net Nonoperating Assets (RNNOA)
-0.16% -0.37% -0.43% -2.76% 0.39% 4.36% 4.49% 1.66% 3.89% 5.63% 3.97%
Return on Equity (ROE)
3.78% -1.43% -1.27% -10.40% 0.79% 16.93% 17.93% 6.61% 15.11% 25.14% 17.99%
Cash Return on Invested Capital (CROIC)
31.52% 27.79% 12.98% 7.76% 3.08% -2.97% 0.62% -1.63% -12.74% 1.08% -2.56%
Operating Return on Assets (OROA)
0.25% 0.83% -0.29% -2.51% 0.12% 3.92% 3.83% 1.38% 3.15% 5.57% 4.15%
Return on Assets (ROA)
0.01% -0.31% -0.33% -1.94% 0.24% 2.97% 3.18% 1.11% 2.73% 4.40% 3.35%
Return on Common Equity (ROCE)
3.78% -1.43% -1.27% -10.40% 0.79% 16.93% 17.93% 6.61% 15.11% 25.14% 17.99%
Return on Equity Simple (ROE_SIMPLE)
12.88% 0.00% -0.04% -4.15% -4.00% 0.00% 6.45% 10.68% 12.72% 0.00% 14.41%
Net Operating Profit after Tax (NOPAT)
36 -10 -7.28 -63 3.01 102 110 40 93 171 127
NOPAT Margin
2.60% -0.68% -0.50% -4.19% 0.20% 6.70% 7.18% 2.58% 6.01% 10.83% 7.99%
Net Nonoperating Expense Percent (NNEP)
4.48% 0.23% 0.60% 0.83% -0.71% -0.79% -0.66% -0.12% -1.18% 0.44% -0.10%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
99.34% 97.88% 100.72% 105.98% 99.72% 90.62% 90.94% 96.72% 92.37% 86.55% 90.02%
Earnings before Interest and Taxes (EBIT)
9.00 32 -10 -90 4.30 142 139 50 118 213 159
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
14 37 -6.20 -86 7.70 145 142 53 120 214 160
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.90 1.95 1.85 1.76 1.83 1.72 1.92 1.77 1.85 1.96 2.05
Price to Tangible Book Value (P/TBV)
2.06 2.12 2.00 1.91 2.00 1.85 2.06 1.90 1.97 2.09 2.18
Price to Revenue (P/Rev)
0.83 0.83 0.79 0.67 0.65 0.71 0.80 0.74 0.87 0.90 1.00
Price to Earnings (P/E)
14.73 39.29 0.00 0.00 0.00 119.96 29.71 16.55 14.56 13.08 14.25
Dividend Yield
2.45% 2.39% 2.51% 2.89% 3.00% 2.77% 2.46% 2.68% 2.30% 2.23% 2.01%
Earnings Yield
6.79% 2.55% 0.00% 0.00% 0.00% 0.83% 3.37% 6.04% 6.87% 7.64% 7.02%
Enterprise Value to Invested Capital (EV/IC)
1.62 1.62 1.58 1.50 1.50 1.45 1.62 1.49 1.55 1.63 1.75
Enterprise Value to Revenue (EV/Rev)
0.94 0.92 0.89 0.78 0.73 0.79 0.88 0.81 0.93 0.96 1.07
Enterprise Value to EBITDA (EV/EBITDA)
15.55 22.31 58.78 0.00 0.00 77.20 25.66 14.27 12.37 11.21 12.29
Enterprise Value to EBIT (EV/EBIT)
16.55 24.29 74.37 0.00 0.00 100.68 27.29 14.75 12.65 11.39 12.44
Enterprise Value to NOPAT (EV/NOPAT)
17.06 29.95 0.00 0.00 0.00 123.52 34.62 18.81 16.50 14.30 15.58
Enterprise Value to Operating Cash Flow (EV/OCF)
6.61 6.97 9.29 8.14 9.31 13.00 13.31 9.61 8.29 7.34 8.54
Enterprise Value to Free Cash Flow (EV/FCFF)
4.53 5.15 11.39 18.36 47.26 0.00 265.32 0.00 0.00 160.17 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.34 0.34 0.33 0.35 0.37 0.32 0.31 0.31 0.27 0.28 0.26
Long-Term Debt to Equity
0.34 0.34 0.33 0.35 0.37 0.32 0.31 0.31 0.27 0.25 0.24
Financial Leverage
0.29 0.29 0.30 0.33 0.35 0.33 0.32 0.33 0.31 0.30 0.28
Leverage Ratio
5.16 5.16 5.35 5.78 6.36 5.96 5.84 6.07 5.94 5.63 5.40
Compound Leverage Factor
0.29 -2.35 9.00 5.85 -1.33 6.29 6.10 6.20 6.54 5.60 5.43
Debt to Total Capital
25.41% 25.11% 24.68% 25.91% 27.01% 24.11% 23.70% 23.49% 21.41% 21.63% 20.48%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.70% 1.61%
Long-Term Debt to Total Capital
25.41% 25.11% 24.68% 25.91% 27.01% 24.11% 23.70% 23.49% 21.41% 19.92% 18.87%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
74.59% 74.89% 75.32% 74.09% 72.99% 75.89% 76.30% 76.51% 78.59% 78.38% 79.52%
Debt to EBITDA
2.45 3.47 9.16 -18.95 -16.38 12.86 3.75 2.26 1.71 1.48 1.43
Net Debt to EBITDA
1.93 2.12 7.04 -14.90 -10.22 7.67 2.49 1.28 0.78 0.66 0.86
Long-Term Debt to EBITDA
2.45 3.47 9.16 -18.95 -16.38 12.86 3.75 2.26 1.71 1.37 1.32
Debt to NOPAT
2.68 4.65 -319.43 -9.14 -9.04 20.58 5.06 2.98 2.28 1.89 1.82
Net Debt to NOPAT
2.12 2.84 -245.35 -7.18 -5.64 12.27 3.35 1.69 1.04 0.84 1.09
Long-Term Debt to NOPAT
2.68 4.65 -319.43 -9.14 -9.04 20.58 5.06 2.98 2.28 1.74 1.68
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
841 800 436 270 182 -31 -24 -276 -669 -206 -395
Operating Cash Flow to CapEx
7,877.50% 5,089.74% 517.14% 793.94% 7,748.28% 4,213.64% 2,257.69% 6,340.91% 16,445.83% 7,116.67% 2,161.11%
Free Cash Flow to Firm to Interest Expense
98.96 93.04 51.26 31.44 21.39 -3.64 -2.84 -32.05 -78.75 -24.21 -46.49
Operating Cash Flow to Interest Expense
37.07 23.08 2.13 3.05 26.44 10.91 6.91 16.22 46.44 25.12 4.58
Operating Cash Flow Less CapEx to Interest Expense
36.60 22.63 1.72 2.66 26.09 10.65 6.60 15.97 46.15 24.76 4.36
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.38 0.39 0.40 0.42 0.43 0.42 0.42 0.42 0.41 0.41 0.42
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,078 3,116 3,172 3,021 2,899 3,249 3,306 3,336 3,662 3,626 3,829
Invested Capital Turnover
1.51 1.56 1.66 1.83 2.00 1.88 1.87 1.92 1.87 1.80 1.75
Increase / (Decrease) in Invested Capital
-806 -810 -443 -333 -179 133 135 315 762 377 523
Enterprise Value (EV)
4,974 5,035 5,020 4,543 4,354 4,702 5,355 4,955 5,686 5,922 6,719
Market Capitalization
4,356 4,558 4,419 3,928 3,866 4,235 4,836 4,509 5,330 5,573 6,249
Book Value per Share
$64.43 $65.62 $67.10 $62.64 $59.19 $68.94 $70.47 $71.01 $79.97 $78.87 $84.74
Tangible Book Value per Share
$59.41 $60.60 $62.08 $57.64 $54.19 $63.94 $65.47 $66.03 $75.00 $73.90 $79.76
Total Capital
3,078 3,116 3,172 3,021 2,899 3,249 3,306 3,336 3,662 3,626 3,829
Total Debt
782 782 783 783 783 783 783 784 784 784 784
Total Long-Term Debt
782 782 783 783 783 783 783 784 784 722 723
Net Debt
617 477 601 615 489 467 519 446 357 349 469
Capital Expenditures (CapEx)
4.00 3.90 3.50 3.30 2.90 2.20 2.60 2.20 2.40 3.00 1.80
Net Nonoperating Expense (NNE)
35 1.81 4.72 6.48 -5.59 -6.17 -5.17 -0.97 -9.21 3.43 -0.80
Net Nonoperating Obligations (NNO)
782 782 783 783 783 783 783 784 784 784 784
Total Depreciation and Amortization (D&A)
5.20 4.30 4.20 3.80 3.40 2.80 2.50 2.50 2.20 1.10 0.50
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.01 ($0.34) ($0.34) ($1.94) $0.24 $3.03 $3.22 $1.13 $2.84 $4.66 $3.56
Adjusted Weighted Average Basic Shares Outstanding
35.60M 35.60M 35.60M 35.70M 35.80M 35.70M 35.80M 36M 36M 35.90M 36M
Adjusted Diluted Earnings per Share
$0.01 ($0.33) ($0.34) ($1.94) $0.24 $3.02 $3.18 $1.12 $2.80 $4.60 $3.50
Adjusted Weighted Average Diluted Shares Outstanding
36.10M 36.10M 35.60M 35.70M 36.10M 36.10M 36.30M 36.30M 36.50M 36.40M 36.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
35.56M 35.60M 35.73M 35.75M 35.76M 35.82M 35.94M 35.98M 36.03M 35.93M 35.92M
Normalized Net Operating Profit after Tax (NOPAT)
21 -10 -7.28 -62 3.01 102 110 42 93 171 127
Normalized NOPAT Margin
1.52% -0.68% -0.50% -4.11% 0.20% 6.70% 7.18% 2.76% 6.04% 10.83% 7.99%
Pre Tax Income Margin
0.04% -0.97% -1.21% -6.05% -0.06% 9.89% 9.46% 3.35% 8.39% 13.36% 10.05%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.06 3.74 -1.22 -10.42 0.51 16.75 16.36 5.84 13.87 25.04 18.72
NOPAT to Interest Expense
4.18 -1.20 -0.86 -7.29 0.35 11.97 12.98 4.60 10.93 20.16 14.99
EBIT Less CapEx to Interest Expense
0.59 3.29 -1.64 -10.80 0.16 16.49 16.06 5.58 13.59 24.68 18.51
NOPAT Less CapEx to Interest Expense
3.71 -1.65 -1.27 -7.68 0.01 11.71 12.67 4.34 10.65 19.80 14.78
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
36.08% 93.88% -12,344.44% -122.20% -136.60% 332.01% 72.97% 44.18% 33.33% 29.13% 28.72%
Augmented Payout Ratio
53.26% 120.43% -13,955.56% -133.41% -136.60% 332.01% 72.97% 44.18% 33.33% 35.40% 37.31%

Key Financial Trends

Overview: In Q1 2025, The Hanover Insurance Group delivered solid top-line growth and improved profitability metrics year-over-year, while maintaining a strong capital position. However, free cash flow remained negative, and operating cash flow dipped significantly compared with the prior quarter.

  • Total revenue rose 3.75% year-over-year to $1.5937 billion in Q1 2025, driven by higher premiums and investment gains.
  • EBITDA increased about 12.95% and EBIT rose 14.63% year-over-year; net income grew 10.99% to $128.2 million.
  • Book value per share climbed to $84.74 from $78.87 a year earlier, reflecting retained earnings growth.
  • Return on invested capital (ROIC) remains robust at 14.01% and return on equity (ROE) near 18.0%.
  • Dividend yield stands at 2.01% with a payout ratio of about 29%, signalling a balanced policy.
  • Leverage metrics remain conservative: debt to equity around 0.26 and net debt to EBITDA below 1.0x.
  • Premiums earned showed modest year-over-year growth to $1.5085 billion, in line with underwriting trends.
  • Free cash flow to firm in Q1 was negative $395.2 million, widening from negative $205.8 million in Q1 2024.
  • Operating cash flow fell to $38.9 million from $213.5 million in Q4 2024, due to working capital changes.
  • Operating expenses remain high at roughly 90% of revenue, limiting net margin expansion.
06/23/25 04:36 AMAI Generated. May Contain Errors.

Frequently Asked Questions About The Hanover Insurance Group's Financials

When does The Hanover Insurance Group's financial year end?

According to the most recent income statement we have on file, The Hanover Insurance Group's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has The Hanover Insurance Group's net income changed over the last 9 years?

The Hanover Insurance Group's net income were at $426 million at the end of 2024, a 1,106.8% increase from 2023, and a 28.5% increase since 2015. View The Hanover Insurance Group's forecast to see where analysts expect The Hanover Insurance Group to go next.

How has The Hanover Insurance Group's revenue changed over the last 9 years?

Over the last 9 years, The Hanover Insurance Group's total revenue changed from $4.99 billion in 2015 to $6.19 billion in 2024, a change of 24.2%.

How much debt does The Hanover Insurance Group have?

The Hanover Insurance Group's total liabilities were at $12.43 billion at the end of 2024, a 2.4% increase from 2023, and a 13.7% increase since 2015.

How much cash does The Hanover Insurance Group have?

In the past 9 years, The Hanover Insurance Group's cash and equivalents has ranged from $120.60 million in 2020 to $1.02 billion in 2018, and is currently $435.50 million as of their latest financial filing in 2024.

How has The Hanover Insurance Group's book value per share changed over the last 9 years?

Over the last 9 years, The Hanover Insurance Group's book value per share changed from 65.77 in 2015 to 78.87 in 2024, a change of 19.9%.



This page (NYSE:THG) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners